Singapore trial under way on use of Lianhua Qingwen in treating mild Covid-19

  • 📰 TODAYonline
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 99%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

SINGAPORE — A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild Covid-19.

The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority in response to CNA's queries on Tuesday .

"A secondary purpose is to assess how it may have a further effect on the time taken to obtain a negative ART test result." A total of 300 people, aged between 21 and 79, are expected to be involved in the trial, according to the clinicaltrials.gov website — an international database of clinical studies maintained by the United States National Library of Medicine.

It added that investigators hypothesise that TCM intervention could reduce the time of eight major Covid-19 symptoms, including fever, sore throat and body aches, as well as reduce the time to a negative ART result for mild coronavirus cases by up to 1.5 times.Lianhua Qingwen is available at some retail shops in Singapore.on social media and in chat groups that Lianhua Qingwen could be used to prevent or treat Covid-19.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I wish there were betting market on this, there's such a low probability of this actually working

Wonder what happened

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Singapore trial under way on use of Lianhua Qingwen in treating mild COVID-19SINGAPORE: A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild COVID-19. The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority ( « Singapore trial » means Singapore will study other countries’ studies. Cute. Allah SWT mengajar umat Islam mengenai Pakistan tetapi mereka tidak memahami begitu juga dgn rakyat Pakistan. Muhammad Qasim melihat bahawa Pakistan mempunyai kepentingan utama dalam Islam dan masa depan umat Islam. Ketahui lebih lanjut tentang hal ini di
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Shares in Chinese pharma firm tank as Covid-19 medicine Lianhua Qingwen questionedSHANGHAI — Shares in one of China's largest traditional medicine producers plunged on Monday (April 18) after reports questioned the efficacy of pills approved by the government as a coronavirus treatment.
Source: TODAYonline - 🏆 1. / 99 Read more »

Shares in Chinese pharma firm tank as COVID-19 medicine Lianhua Qingwen questionedShares in one of China\u0027s largest traditional medicine producers plunged on Monday (Apr 18) after reports questioned the efficacy of pills approved by the government as a coronavirus treatment. Shanghai au TripperheadToo linjack88 ...you dont say...nooo...really? Lol anyone who believes Chinese medicine can cure anything should talk to DrJasonLeong This makes China looks bad… very bad.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Shares in Chinese pharma firm tank as Covid-19 medicine Lianhua Qingwen questionedSHANGHAI — Shares in one of China's largest traditional medicine producers plunged on Monday (April 18) after reports questioned the efficacy of pills approved by the government as a coronavirus treatment. Shanghai authorities have joined their Hong Kong counterparts in... Another scam
Source: thenewpaper - 🏆 7. / 63 Read more »

HSA grants interim authorisation for oral Covid-19 drug molnupiravirSINGAPORE — The Health Sciences Authority (HSA) on Tuesday (April 19) granted interim authorisation for the use of molnupiravir as an oral treatment for mild to moderate Covid-19.
Source: TODAYonline - 🏆 1. / 99 Read more »